{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:13:17Z","timestamp":1778209997323,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14471-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:00:47Z","timestamp":1751353247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of PRKCQ variants with breast cancer susceptibility and clinicopathological features"],"prefix":"10.1186","volume":"25","author":[{"given":"Amna","family":"Hafeez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Badshah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andleeb","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janeen H.","family":"Trembley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyaba","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dara","family":"Aldisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhail","family":"Razak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"14471_CR1","first-page":"20182020","volume-title":"Global cancer observatory: cancer today","author":"J Ferlay","year":"2020","unstructured":"Ferlay J, et al. Global cancer observatory: cancer today. Lyon: International agency for research on cancer; 2020. p. 20182020."},{"issue":"17","key":"14471_CR2","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.3390\/cancers14174218","volume":"14","author":"YX Lim","year":"2022","unstructured":"Lim YX, et al. Breast cancer in asia: incidence, mortality, early detection, mammography programs, and risk-based screening initiatives. Cancers. 2022;14(17):4218.","journal-title":"Cancers"},{"key":"14471_CR3","doi-asserted-by":"crossref","unstructured":"Chauhan S, Mathur R, Jha AK. The impact of MicroRNA SNPS on breast cancer: potential biomarkers for disease detection. Mol Biotechnol. 2024:1\u201317.","DOI":"10.1007\/s12033-024-01113-w"},{"issue":"6","key":"14471_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s12282-024-01628-9","volume":"31","author":"H Ganatra","year":"2024","unstructured":"Ganatra H, et al. Applying whole-genome and whole-exome sequencing in breast cancer: A review of the landscape. Breast Cancer. 2024;31(6):999\u20131009.","journal-title":"Breast Cancer"},{"key":"14471_CR5","doi-asserted-by":"publisher","first-page":"798319","DOI":"10.3389\/fcell.2021.798319","volume":"9","author":"A Abdelatty","year":"2022","unstructured":"Abdelatty A, et al. Pan-cancer study on protein kinase C family as a potential biomarker for the tumors immune landscape and the response to immunotherapy. Front Cell Dev Biology. 2022;9:798319.","journal-title":"Front Cell Dev Biology"},{"key":"14471_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-020-01302-w","volume":"22","author":"JH Byerly","year":"2020","unstructured":"Byerly JH, Port ER, Irie HY. PRKCQ Inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim. Breast Cancer Res. 2020;22:1\u201310.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"14471_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1042\/BCJ20240148","volume":"481","author":"SJ Hodapp","year":"2024","unstructured":"Hodapp SJ, et al. Cancer-associated mutations in protein kinase C theta are loss-of-function. Biochem J. 2024;481(12):759\u201375.","journal-title":"Biochem J"},{"key":"14471_CR8","doi-asserted-by":"crossref","unstructured":"Collins A, Ke X. Primer1: primer design web service for tetra-primer ARMS-PCR. Open Bioinf J. 2012;6(1).","DOI":"10.2174\/1875036201206010055"},{"issue":"5","key":"14471_CR9","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jid.2021.09.024","volume":"142","author":"N Garc\u00eda-D\u00edaz","year":"2022","unstructured":"Garc\u00eda-D\u00edaz N, et al. PLC\u03b31\/PKC\u03b8 downstream signaling controls cutaneous T-cell lymphoma development and progression. J Invest Dermatology. 2022;142(5):1391\u2013400. e15.","journal-title":"J Invest Dermatology"},{"issue":"1","key":"14471_CR10","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/15476286.2022.2139110","volume":"19","author":"K Khan","year":"2022","unstructured":"Khan K, et al. PRKCE non-coding variants influence on transcription as well as translation of its gene. RNA Biol. 2022;19(1):1115\u201329.","journal-title":"RNA Biol"},{"issue":"36","key":"14471_CR11","doi-asserted-by":"publisher","first-page":"30518","DOI":"10.1074\/jbc.M112.391557","volume":"287","author":"RV Stahelin","year":"2012","unstructured":"Stahelin RV, et al. Protein kinase C\u03b8 C2 domain is a phosphotyrosine binding module that plays a key role in its activation. J Biol Chem. 2012;287(36):30518\u201328.","journal-title":"J Biol Chem"},{"key":"14471_CR12","doi-asserted-by":"publisher","first-page":"155888","DOI":"10.1016\/j.cyto.2022.155888","volume":"154","author":"Q Xu","year":"2022","unstructured":"Xu Q, et al. Crocin attenuates NF-\u03baB-mediated inflammation and proliferation in breast cancer cells by down-regulating PRKCQ. Cytokine. 2022;154:155888.","journal-title":"Cytokine"},{"issue":"1","key":"14471_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41568-020-00310-4","volume":"21","author":"PJ Parker","year":"2021","unstructured":"Parker PJ, et al. Equivocal, explicit and emergent actions of PKC isoforms in cancer. Nat Rev Cancer. 2021;21(1):51\u201363.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"14471_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000179561","volume":"67","author":"AD Overall","year":"2009","unstructured":"Overall AD. The influence of the Wahlund effect on the consanguinity hypothesis: consequences for recessive disease incidence in a socially structured Pakistani population. Human Hered. 2009;67(2):140\u20134.","journal-title":"Human Hered"},{"issue":"4","key":"14471_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejmhg.2017.01.002","volume":"18","author":"A Bener","year":"2017","unstructured":"Bener A, Mohammad RR. Global distribution of consanguinity and their impact on complex diseases: genetic disorders from an endogamous population. Egypt J Med Hum Genet. 2017;18(4):315\u201320.","journal-title":"Egypt J Med Hum Genet"},{"key":"14471_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fgene.2017.00167","volume":"8","author":"B Chen","year":"2017","unstructured":"Chen B, Cole JW, Grond-Ginsbach C. Departure from hardy Weinberg equilibrium and genotyping error. Front Genet. 2017;8:167.","journal-title":"Front Genet"},{"key":"14471_CR17","doi-asserted-by":"crossref","unstructured":"Wang S et al. Association between single-nucleotide polymorphisms in breast cancer susceptibility genes and clinicopathological characteristics. Clin Epidemiol. 2021:103\u201312.","DOI":"10.2147\/CLEP.S292429"},{"key":"14471_CR18","unstructured":"Ma B, Wu J, Ma B. Association between single nucleotide polymorphism of BRCA1-interacting protein C-terminal helicase 1 and early-onset breast cancer in Uygur and Han women in Xinjiang of China. Volume 33. Biotechnology & Biotechnological Equipment. 2019;33(1):1750\u20136."},{"issue":"19","key":"14471_CR19","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.7150\/jca.33857","volume":"10","author":"LN Al-Eitan","year":"2019","unstructured":"Al-Eitan LN, et al. Correlation between candidate single nucleotide variants and several clinicopathological risk factors related to breast cancer in Jordanian women: a genotype-phenotype study. J Cancer. 2019;10(19):4647.","journal-title":"J Cancer"},{"issue":"2","key":"14471_CR20","first-page":"266","volume":"15","author":"B Lu","year":"2024","unstructured":"Lu B, Natarajan E. Combination therapy strategies and advanced biomarkers can potentially enhance the Precision-Medicine treatment of metastatic breast cancer. J Nat Sci Biology Med. 2024;15(2):266.","journal-title":"J Nat Sci Biology Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14471-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14471-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:00:50Z","timestamp":1751353250000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14471-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14471"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14471-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved (Ref: No. IRB No. 04-2019-03\/06) by the Ethics Committee of Combined Military Hospital and ASAB, NUST. Research was conducted in accordance with the Helsinki Declaration. Informed Consent was taken from all participants regarding the study\u2019s purpose, risks, and benefits.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1069"}}